Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.08 AUD | +8.78% | +16.78% | +167.37% |
May. 30 | Clarity Pharmaceuticals Signs Supply Deal for Copper Isotope | MT |
Apr. 24 | Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer | MT |
Business Summary
Number of employees: 41
Managers
Managers | Title | Age | Since |
---|---|---|---|
Colin Biggin
CEO | Chief Executive Officer | - | 16-12-31 |
Matthew Harris
FOU | Founder | - | 09-12-31 |
David Green
DFI | Director of Finance/CFO | - | 21-12-31 |
Shaemus Gleason
COO | Chief Operating Officer | - | 21-04-30 |
Chief Tech/Sci/R&D Officer | - | 22-09-12 | |
Ellen van Dam
CTO | Chief Tech/Sci/R&D Officer | - | 14-03-31 |
Michelle Parker
CTO | Chief Tech/Sci/R&D Officer | - | 18-05-31 |
Catherine Strong
IRC | Investor Relations Contact | - | - |
Mike Ironside
PRN | Corporate Officer/Principal | - | 20-05-31 |
General Counsel | - | 19-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | - |
Robert Thomas
BRD | Director/Board Member | 79 | 21-08-24 |
Thomas Ramdahl
BRD | Director/Board Member | 68 | - |
Matthew Harris
FOU | Founder | - | 09-12-31 |
Alan Taylor
CHM | Chairman | - | - |
Director/Board Member | - | - | |
Colin Biggin
CEO | Chief Executive Officer | - | 16-12-31 |
David Green
DFI | Director of Finance/CFO | - | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 271,098,503 | 219,473,085 ( 80.96 %) | 0 | 80.96 % |
Company contact information
Clarity Pharmaceuticals Ltd.
National Innovation Centre 4 Cornwallis Street
2015, Eveleigh
+
http://www.claritypharmaceuticals.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+167.37% | 1.05B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CU6 Stock
- Company Clarity Pharmaceuticals Ltd